These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 25682993)

  • 41. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
    Mohammed Vashist N; Samaan M; Mosli MH; Parker CE; MacDonald JK; Nelson SA; Zou GY; Feagan BG; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011450. PubMed ID: 29338066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis.
    Ponte A; Pinho R; Fernandes S; Rodrigues A; Alberto L; Silva JC; Silva J; Rodrigues J; Sousa M; Silva AP; Proença L; Freitas T; Leite S; Carvalho J
    Inflamm Bowel Dis; 2017 Dec; 23(12):2238-2244. PubMed ID: 28991857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience.
    Laharie D; Filippi J; Roblin X; Nancey S; Chevaux JB; Hébuterne X; Flourié B; Capdepont M; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2013 May; 37(10):998-1004. PubMed ID: 23521659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.
    Calafat M; Lobatón T; Hernández-Gallego A; Mañosa M; Torres P; Cañete F; Cabré E; Ojanguren I; Domènech E
    Dig Liver Dis; 2017 Dec; 49(12):1327-1331. PubMed ID: 28958412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients.
    Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Mertz Nielsen A
    J Crohns Colitis; 2015 Aug; 9(8):625-32. PubMed ID: 25956537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis.
    Kerur B; Litman HJ; Stern JB; Weber S; Lightdale JR; Rufo PA; Bousvaros A
    World J Gastroenterol; 2017 May; 23(18):3322-3329. PubMed ID: 28566893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azathioprine Is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis.
    Nishida Y; Hosomi S; Yamagami H; Sugita N; Itani S; Yukawa T; Otani K; Nagami Y; Tanaka F; Taira K; Kamata N; Kakimoto K; Tanigawa T; Watanabe T; Fujiwara Y
    Intern Med; 2019 Aug; 58(16):2305-2313. PubMed ID: 31118391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustained remission after steroids and leukocytapheresis induced response in steroid-dependent ulcerative colitis: results at 1 year.
    Cabriada JL; Ibargoyen N; Hernández A; Bernal A; Castiella A
    Dig Liver Dis; 2010 Jun; 42(6):432-5. PubMed ID: 19833566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis.
    Ogata H; Kato J; Hirai F; Hida N; Matsui T; Matsumoto T; Koyanagi K; Hibi T
    Inflamm Bowel Dis; 2012 May; 18(5):803-8. PubMed ID: 21887732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucosal gene transcription of ulcerative colitis in endoscopic remission.
    Arkteg CB; Goll R; Gundersen MD; Anderssen E; Fenton C; Florholmen J
    Scand J Gastroenterol; 2020 Feb; 55(2):139-147. PubMed ID: 31918598
    [No Abstract]   [Full Text] [Related]  

  • 51. EFFICACY OF TACROLIMUS FOR INDUCTION OF REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Lasa J; Olivera P
    Arq Gastroenterol; 2017; 54(2):167-172. PubMed ID: 28327826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical implications of histologic abnormalities in colonic biopsy specimens from patients with ulcerative colitis in clinical remission.
    Feagins LA; Melton SD; Iqbal R; Dunbar KB; Spechler SJ
    Inflamm Bowel Dis; 2013 Jun; 19(7):1477-82. PubMed ID: 23702713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of cyclosporin with corticotropin for refractory ulcerative colitis.
    Okamura S; Aoki H; Ohashi S; Urano F; Shimodaira M; Kanamori S; Ishikawa H; Segawa K
    Hepatogastroenterology; 2003; 50(49):91-4. PubMed ID: 12629999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral tacrolimus treatment of severe colitis in children.
    Bousvaros A; Kirschner BS; Werlin SL; Parker-Hartigan L; Daum F; Freeman KB; Balint JP; Day AS; Griffiths AM; Zurakowski D; Ferry GD; Leichtner AM
    J Pediatr; 2000 Dec; 137(6):794-9. PubMed ID: 11113835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.
    Sandborn WJ; Hanauer S; Lichtenstein GR; Safdi M; Edeline M; Scott Harris M
    Aliment Pharmacol Ther; 2011 Oct; 34(7):747-56. PubMed ID: 21848857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Appropriate Timing of Discontinuation of Tacrolimus Therapy for Refractory Ulcerative Colitis.
    Matsumoto S; Otake H; Sekine M; Uehara T; Miyatani H; Mashima H
    Clin Drug Investig; 2019 Aug; 39(8):737-744. PubMed ID: 31065933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease.
    Beppu T; Ono Y; Matsui T; Hirai F; Yano Y; Takatsu N; Ninomiya K; Tsurumi K; Sato Y; Takahashi H; Ookado Y; Koga A; Kinjo K; Nagahama T; Hisabe T; Takaki Y; Yao K
    Dig Endosc; 2015 Jan; 27(1):73-81. PubMed ID: 24833527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of Endoscopic Mucosal Healing of Ulcerative Colitis Using Linked Colour Imaging, a Novel Endoscopic Enhancement System.
    Uchiyama K; Takagi T; Kashiwagi S; Toyokawa Y; Tanaka M; Hotta Y; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Ishikawa T; Handa O; Konishi H; Kishimoto M; Yagi N; Naito Y; Itoh Y
    J Crohns Colitis; 2017 Aug; 11(8):963-969. PubMed ID: 28333209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.